undamentalytics Newsletter
Sign in

Agilon Health, Inc. revenue

Agilon Health, Inc.'s revenue was $5.93bn in fiscal 2025, down 2.1% on the year before. Since fiscal 2019 ($794m) it has grown at a compound 39.8% a year. Over the last twelve months it was $5.92bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue7941,2181,5212,3884,3166,0615,9335,920
Growth on the year before—+53.4%+24.9%+57.0%+80.7%+40.4%−2.1%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Medical Services $5.9B 99.8% ▼ 2.1%
Other Operating $11.2M 0.2% ▼ 12.3%

From Agilon Health, Inc.'s 10-K filed February 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Agilon Health, Inc. $5.92bn 0.3% 22.9%
Option Care Health, Inc. $5.69bn 5.9% 11.3%
Astrana Health, Inc. $3.84bn 58.9% 43.7%
AMN Healthcare Services Inc $3.43bn 24.0% -7.8%
Quest Diagnostics $11.84bn 9.1% 8.4%
Chemed Corp $2.66bn 5.2% 6.1%

Compare with peers

Head to head: AGL vs OPCHAGL vs ASTHAGL vs AMN

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Agilon Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Agilon Health, Inc.